One Eleven Interactive, Inc

Innovative marketing programs for the pharmaceutical industry

One Eleven Interactive, Inc Contact Drugmaker to spend $1 billion to fight diabetes in the US

Drugmaker to spend $1 billion to fight diabetes in the US



Regeneron Pharmaceuticals Inc. is planning to spend at least $1.5 billion to battle diabetes in people in the United States, according to a document posted on the company’s website.

The company, which is developing a drug to fight Type 1 diabetes, said it was investing in a new diabetes drug development and development lab in San Diego, California.

The lab will help Regeneron develop and produce insulin and other treatments, according the company.

The $1 million investment was made in April, Regeneron said.

The diabetes drug company is the latest in a growing number of drug companies to take advantage of a global pandemic to expand its development efforts in the U.S. Regeneron also has an office in the San Francisco Bay Area.

TopBack to Top